Literature DB >> 30895427

Right ventricular diameter predicts all-cause mortality in heart failure with preserved ejection fraction.

Gaspare Parrinello1, Daniele Torres2, Silvio Buscemi2, Tiziana Di Chiara2, Francesco Cuttitta2, Mauro Cardillo2, Francesca Romana Pluchinotta3, Rosario Scaglione2, Salvatore Paterna2, Antonio Pinto2.   

Abstract

Left ventricular ejection fraction (EF) is helpful to differentiate heart failure (HF) phenotype in clinical practice. The aim of the study was to identify simple echocardiographic predictors of post-discharge all-cause mortality in hospitalized HF patients. Patients with acute HF (75 ± 9.8 years), classified in preserved (≥ 50%) and reduced (< 50%) EF (HFpEF and HFrEF, respectively), were enrolled. The mean follow-up period was of 25.4 months. Patients definitively analyzed were 135. At multivariate Cox model, right ventricular diameter (RVd), inferior vena cava diameter (IVCd) and blood urea nitrogen (BUN) resulted to be significantly associated with all-cause mortality in HFpEF (HR 2.4, p = 0.04; HR 1.06, p = 0.02; HR 1.02, p = 0.01), whereas, left atrial volume (LAV) was significantly associated with mortality in HFrEF (HR 1.06, p = 0.006). Excluding LAV from the model, only COPD remained an independent predictor of all-cause mortality (HR 2.15, p = 0.04) in HFrEF. At Kaplan-Meier analysis, no differences of survival between HFrEF and HFpEF were found, however, significantly increased all-cause mortality for higher values of basal-RVd, BUN, and IVCd (log-rank p = 0.0065, 0.0063, 0.0005) in HFpEF, and for COPD and higher LAV (log-rank p = 0.0046, p = 0.033) in HFrEF. These data are indicative that in patients hospitalized with HF, EF is not a suitable predictor of long-term all-cause mortality, whereas, right ventricular volumetric remodeling and IVCd have a prognostic role in HFpEF as well as LAV in HFrEF. Our study suggests that besides EF, other echocardiographic parameters are helpful to optimize the phenotyping and prognostic stratification of HF.

Entities:  

Keywords:  Cardiac remodeling; Ejection fraction; Heart failure; Mortality; Right ventricular diameter

Mesh:

Year:  2019        PMID: 30895427     DOI: 10.1007/s11739-019-02071-x

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


  30 in total

Review 1.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 2.  Right ventricular function in cardiovascular disease, part II: pathophysiology, clinical importance, and management of right ventricular failure.

Authors:  François Haddad; Ramona Doyle; Daniel J Murphy; Sharon A Hunt
Journal:  Circulation       Date:  2008-04-01       Impact factor: 29.690

Review 3.  Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance.

Authors:  William A Zoghbi; David Adams; Robert O Bonow; Maurice Enriquez-Sarano; Elyse Foster; Paul A Grayburn; Rebecca T Hahn; Yuchi Han; Judy Hung; Roberto M Lang; Stephen H Little; Dipan J Shah; Stanton Shernan; Paaladinesh Thavendiranathan; James D Thomas; Neil J Weissman
Journal:  J Am Soc Echocardiogr       Date:  2017-03-14       Impact factor: 5.251

4.  p53-induced inhibition of Hif-1 causes cardiac dysfunction during pressure overload.

Authors:  Masanori Sano; Tohru Minamino; Haruhiro Toko; Hideyuki Miyauchi; Masayuki Orimo; Yingjie Qin; Hiroshi Akazawa; Kaoru Tateno; Yosuke Kayama; Mutsuo Harada; Ippei Shimizu; Takayuki Asahara; Hirofumi Hamada; Shuhei Tomita; Jeffrey D Molkentin; Yunzeng Zou; Issei Komuro
Journal:  Nature       Date:  2007-03-04       Impact factor: 49.962

Review 5.  Myofibroblast-mediated mechanisms of pathological remodelling of the heart.

Authors:  Karl T Weber; Yao Sun; Syamal K Bhattacharya; Robert A Ahokas; Ivan C Gerling
Journal:  Nat Rev Cardiol       Date:  2012-12-04       Impact factor: 32.419

Review 6.  Epidemiology and risk stratification in acute heart failure.

Authors:  Gregg C Fonarow
Journal:  Am Heart J       Date:  2007-11-26       Impact factor: 4.749

7.  Albuminuria is independently associated with cardiac remodeling, abnormal right and left ventricular function, and worse outcomes in heart failure with preserved ejection fraction.

Authors:  Daniel H Katz; Jacob A Burns; Frank G Aguilar; Lauren Beussink; Sanjiv J Shah
Journal:  JACC Heart Fail       Date:  2014-10-01       Impact factor: 12.035

8.  Prognostic value of blood urea nitrogen in patients hospitalized with worsening heart failure: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) study.

Authors:  Gerasimos Filippatos; Joseph Rossi; Donald M Lloyd-Jones; Wendy Gattis Stough; John Ouyang; David D Shin; Christopher O'connor; Kirkwood F Adams; Cesare Orlandi; Mihai Gheorghiade
Journal:  J Card Fail       Date:  2007-06       Impact factor: 5.712

9.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

Review 10.  Heart Failure: Diagnosis, Management and Utilization.

Authors:  Arati A Inamdar; Ajinkya C Inamdar
Journal:  J Clin Med       Date:  2016-06-29       Impact factor: 4.241

View more
  4 in total

1.  Risk stratification in hospitalized heart failure patients: do the RIGHT thing!

Authors:  Alberto Maria Marra; Marco Proietti; Eduardo Bossone; Andrea Salzano; Antonio Cittadini
Journal:  Intern Emerg Med       Date:  2019-06-18       Impact factor: 3.397

2.  Clinical significance of left atrial geometry in dilated cardiomyopathy patients: A cardiovascular magnetic resonance study.

Authors:  Mayu Yazaki; Takeru Nabeta; Takayuki Inomata; Kenji Maemura; Takumi Oki; Teppei Fujita; Yuki Ikeda; Shunsuke Ishii; Takashi Naruke; Yusuke Inoue; Junya Ako
Journal:  Clin Cardiol       Date:  2020-12-09       Impact factor: 2.882

3.  A longitudinal study of cardiac structure and function using echocardiography in patients undergoing peritoneal dialysis.

Authors:  Yunyun Zhu; Difei Zhang; Xiaoxuan Hu; Hui Liu; Yuan Xu; Haijing Hou; Yu Peng; Ying Lu; Xusheng Liu; Fuhua Lu
Journal:  BMC Nephrol       Date:  2021-10-16       Impact factor: 2.388

4.  Diagnostic Values of Blood Urea Nitrogen (BUN), Creatinine (Cr), and the Ratio of BUN to Cr for Distinguishing Heart Failure from Asthma and Chronic Obstructive Pulmonary Disease.

Authors:  Jingjing Zhang; Ling Zhou; Yuezhan Zhang
Journal:  Comput Math Methods Med       Date:  2022-07-21       Impact factor: 2.809

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.